TNS2 inhibits AKT/PKB signaling via C1-TEN (C1 domain-containing phosphatase and TENsin homologue) and mediates TPO (Thrombopoietin)/c-Mpl pathway [51], which engages AKT signaling in induction of cancer growth [52]. Here, THPO is linked to cancer.